Security
DTRT Health Acquisition Corp. Class A Common Stock · DTRT
DTRTNASDAQCommon stockHistorical · closed Feb 1, 2023CIK 1865537Updated Nov 16, 2026
DTRT price & chart
Historical security
This listing closed Feb 1, 2023. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2021 · USDSource
Source
balance sheet · annual statements
| Line item | Q3 2022 | Q3 2021 | Q2 2022 | Q2 2021 | Q1 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| AssetsUSD | 236,170,855Source | 237,104,532Source | 235,375,798Source | 357,796Source | 235,558,446Source | 235,820,174Source |
| Current assets: | ||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | 1,460,691Source | — | 24,049Source | — | 342,152Source |
| Assets, CurrentUSD | 559,231Source | 2,499,958Source | 783,593Source | 24,049Source | 937,146Source | 1,203,370Source |
| LIABILITIES AND EQUITY | ||||||
| LiabilitiesUSD | 12,044,085Source | 25,086,948Source | 9,087,594Source | 375,834Source | 11,166,985Source | 14,184,248Source |
| Stockholders’ equity: | ||||||
| Additional Paid in CapitalUSD | 0Source | 0Source | 0Source | 24,425Source | 0Source | 0Source |
| Retained Earnings (Accumulated Deficit)USD | -11,067,865Source | -22,582,991Source | -8,312,371Source | -43,038Source | -10,209,114Source | -12,964,649Source |
| Stockholders' Equity Attributable to ParentUSD | -11,067,290Source | -22,582,416Source | -8,311,796Source | -18,038Source | -10,208,539Source | -12,964,074Source |
| Liabilities and EquityUSD | 236,170,855Source | 237,104,532Source | 235,375,798Source | 357,796Source | 235,558,446Source | 235,820,174Source |
| Current liabilities: | ||||||
| Liabilities, CurrentUSD | 522,085Source | 1,244,948Source | 253,594Source | — | 316,985Source | 310,248Source |
| Additional Financial Items | ||||||
| Accrued Liabilities, CurrentUSD | 143,100Source | 126,381Source | 172,900Source | 274,500Source | 185,200Source | 164,900Source |
| Accounts Payable, Current | —Source | —Source | —Source | —Source | —Source | — |
cash flow · annual statements
| Line item | Q3 2022 | Q3 2021 | Q2 2022 | Q2 2021 | Q1 2022 |
|---|---|---|---|---|---|
| Net Cash Provided by (Used in) Operating Activities | — | — | — | —Source | —Source |
| Net Cash Provided by (Used in) Investing Activities | — | — | — | —Source | —Source |
| Net Cash Provided by (Used in) Financing Activities | — | — | — | —Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | — | —Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | —Source | —Source | —Source | —Source | —Source |
| General and Administrative Expense | —Source | —Source | —Source | —Source | —Source |
| Income Tax Expense (Benefit) | —Source | —Source | — | — | — |
| Investment Income, Interest | — | — | — | —Source | —Source |
| Net Income (Loss) Attributable to Parent | —Source | —Source | —Source | —Source | —Source |
| Other Nonoperating Income (Expense) | — | —Source | —Source | —Source | —Source |
| Proceeds from Issuance of Common Stock | — | — | — | —Source | — |
income statement · annual statements
| Line item | Q3 2022 | Q3 2021 | Q2 2022 | Q2 2021 | Q1 2022 |
|---|---|---|---|---|---|
| Operating Income (Loss) | —Source | —Source | —Source | —Source | —Source |
| Other Nonoperating Income (Expense) | — | —Source | —Source | —Source | —Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | —Source | —Source | — | — | — |
| Income Tax Expense (Benefit) | —Source | —Source | — | — | — |
| Net Income (Loss) Attributable to Parent | —Source | —Source | —Source | —Source | —Source |
| General and Administrative Expense | —Source | —Source | —Source | —Source | —Source |
| Interest Income, Other | —Source | —Source | —Source | —Source | —Source |
| Investment Income, Interest | — | — | — | —Source | —Source |